| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |